%20--%3e%3c!DOCTYPE%20svg%20PUBLIC%20'-//W3C//DTD%20SVG%201.1//EN'%20'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'%20[%20%3c!ENTITY%20st0%20'fill:%23267E9A;'%3e%3c!ENTITY%20st1%20'fill:%2378C9DA;'%3e%3c!ENTITY%20st2%20'fill:%23FFFFFF;'%3e%3c!ENTITY%20st3%20'fill:%23085580;'%3e%3c!ENTITY%20st4%20'fill:%2386C34A;'%3e%3c!ENTITY%20st5%20'fill:%232FBBCC;'%3e%3c!ENTITY%20st6%20'fill:%234C6F90;'%3e%3c!ENTITY%20st7%20'fill:%23194670;'%3e%3c!ENTITY%20st8%20'fill:%2307557E;'%3e%3c!ENTITY%20st9%20'fill:%23516E89;'%3e%20]%3e%3csvg%20version='1.1'%20id='Layer_1'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%2032%2032'%20style='enable-background:new%200%200%2032%2032;'%20xml:space='preserve'%3e%3cg%3e%3cg%3e%3crect%20x='10.3'%20y='14'%20style='&st5;'%20width='5'%20height='4.4'/%3e%3crect%20x='10.3'%20y='12'%20style='&st5;'%20width='11.4'%20height='1'/%3e%3crect%20x='16.4'%20y='14'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='15.8'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='17.5'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='19.3'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='10.3'%20y='19.3'%20style='&st5;'%20width='5'%20height='0.9'/%3e%3cg%3e%3cpath%20style='&st5;'%20d='M22.6,22.3H9.4c-0.6,0-1.2-0.5-1.2-1.2v-10c0-0.6,0.5-1.2,1.2-1.2h13.1c0.6,0,1.2,0.5,1.2,1.2v10%20C23.7,21.7,23.2,22.3,22.6,22.3z%20M9.4,10.8c-0.1,0-0.3,0.1-0.3,0.3v10c0,0.1,0.1,0.3,0.3,0.3h13.1c0.1,0,0.3-0.1,0.3-0.3v-10%20c0-0.1-0.1-0.3-0.3-0.3H9.4z'/%3e%3c/g%3e%3c/g%3e%3cpath%20style='&st5;'%20d='M16,30.2C8.2,30.2,1.8,23.8,1.8,16S8.2,1.8,16,1.8S30.2,8.2,30.2,16S23.8,30.2,16,30.2z%20M16,2.8%20C8.7,2.8,2.8,8.7,2.8,16S8.7,29.2,16,29.2S29.2,23.3,29.2,16S23.3,2.8,16,2.8z'/%3e%3c/g%3e%3c/svg%3e)
Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
IOL News
10/30/2026
BreakingCornealDry EyeGlaucomaIOLLaserPremiumPresbyopiaRetinaRevenue
Q3-2026 Ophthalmic Revenue Roundup for Bausch + Lomb, Glaukos, Novartis, Lumibird, and Lenz
Bausch + Lomb reported Oct. 28 that its Q3-2026 revenue totaled $1.4 billion, a 7 percent increase (+8 percent cc) from $1.3 billion in Q3-2025. Ophthalmic pharmaceuticals segment revenue was $367 ...
10/23/2026
BreakingCataractIOLPharmaPremiumRetinaRevenueSurgical
Q3-2026 Ophthalmic Revenue Roundup for Roche and J&J Vision
Swiss company Roche reported Oct. 22 that Q3-2026 Vabysmo sales were CHF 1.1 billion ($1.4 billion, converted for Sept. 20, 2026) a 13 percent increase over CHF 996 million in Q3-2025. US Vabysmo s...
10/21/2026
ESCRSIOLLaserMeetingNewsletterRefractiveSurgical
Lens-vs.-Laser Debate Heats Up at ESCRS Congress as New Refractive Technologies are Launched
The long-running debate between laser- and lens-based refractive surgery intensified at the 2026 ESCRS congress in London, where new product launches and packed scientific sessions underscored a ma...
10/21/2026
DealsIOLNewsletterRetina
Saunders Departs Bausch + Lomb, as Chairman Appio Takes Over
Bausch + Lomb announced Oct. 12 that CEO Brent Saunders would leave the company immediately, with chairman Thomas Appio taking over as interim CEO. Appio also is CEO of Bausch Health. Saunders had ...
10/21/2026
IOLNewsletterRegulation
Rayner Launches RayOne Galaxy IOL in US after Receiving FDA Approval
UK-based Rayner announced Sept. 24 that its RayOne Galaxy and RayOne Galaxy Toric IOLs were commercially available in the US after the lenses gained FDA approval. The Galaxy is the first-ever spira...
10/21/2026
CataractDiagnosticIOLNewsletter
Select US FDA Approvals and Clearances in September 2026
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in September 2026, according to the agency’s database. Kowa received clearance for its updated FM...
10/21/2026
DealsGlaucomaIOLNewsletterPremium
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Pharma announced Oct. 1 that it had acquired all outstanding shares of Advanced Vision Science (AVS), a manufacturer of intraocular lenses and lens materials, for $13 million in cash. AVS,...
10/21/2026
DealsDiagnosticIOLNewsletterPremium
Carrot, Maker of VR Visual Field Testing, Acquires IOL Simulation Developer GreenMan
Carrot (formerly Virtual Field) reported Oct. 9 that it had agreed to acquire GreenMan Vision, of West Fargo, North Dakota, and its InSightVR IOL simulator. No financial details were provided. The ...
10/21/2026
AICataractDiagnosticDigitalDry EyeEmergingIOLMyopiaNewsletterOculomicsRetinaSurgical
Emerging Companies Pursuing Ophthalmic Indications, October 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
10/9/2026
BreakingCataractDealsDiagnosticGlaucomaIOLPerimetryPremium
Carrot, Maker of VR Visual Field Testing, Acquires IOL Simulation Developer GreenMan
Carrot (formerly Virtual Field) reported Oct. 9 that it had agreed to acquire GreenMan Vision, of West Fargo, North Dakota, and its InSightVR IOL simulator. No financial details were provided. The ...
10/2/2026
BreakingDealsGlaucomaIOL
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Pharma announced Oct. 1 that it had acquired all outstanding shares of common stock in Advanced Vision Science (AVS), a manufacturer of intraocular lenses and lens materials, for $13 milli...
10/2/2026
BreakingCataractIOLPremiumSurgical
InSightVR IOL Simulator Linked to Increased Premium Lens Selection, Better Understanding
GreenMan Vision, of West Fargo, North Dakota, reported Sept. 21 that its InSightVR IOL simulator was associated with several key benefits in a study published Sept. 5 in the journal Patient Prefere...
9/25/2026
BreakingCataractIOLRegulationSurgical
Rayner Launches RayOne Galaxy IOL in US after Receiving FDA Approval
UK-based Rayner announced Sept. 24 that its RayOne Galaxy and RayOne Galaxy Toric IOLs were commercially available in the US after the lenses gained FDA approval. The company noted that US surgeons...
9/22/2026
GlaucomaIOLNewsletterRefractiveRetina
Ophthalmologists Report 5.4 Percent Decrease in Q2-2026 Procedure Volume
US ophthalmologists reported that ophthalmic procedures decreased 5.4 percent in Q2-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...
9/22/2026
DiagnosticEuropeIOLMicroscopesNewsletterRegulation
Alcon Launches Unity M Ophthalmic Surgical Microscope
Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...
9/22/2026
AIChinaDealsDry EyeEuropeGlaucomaIOLIndustryLow VisionMyopiaNewsletterPharmaPresbyopiaRetinaSurgical
September 2026 Ophthalmic News Briefs
UK-based Rayner reported Sept. 7 the launch of its Galaxy Hydrophobic spiral IOL. The lens will be available commercially in the EU in Q4-2026. The original Galaxy spiral IOL, a full range of visio...
9/11/2026
BreakingCataractIOLMeeting
Rayner Launches Galaxy Hydrophobic Spiral IOL
UK-based Rayner reported Sept. 7 the launch of its Galaxy Hydrophobic spiral IOL at the 2026 ESCRS congress in London. The lens will be available commercially in the EU in Q4-2026. The original Gal...
9/11/2026
BreakingCataractEuropeIOLMeeting
Zeiss Announces Launch of AT Lucia Toric 721P
Zeiss Medical Technology reported Sept. 10 that it was launching its AT Lucia Toric 721P IOL at the 2026 ESCRS congress in London. Zeiss, of Germany, described the lens as the world's first hyd...
9/11/2026
BreakingCataractEuropeIOL
Alcon’s Clareon Monofocal Lens Gains MDR Certification, Expanded Labeling
Alcon reported Sept. 1 that it had gained MDR certification in the European Union for its Clareon Monofocal enhanced monofocal intraocular lens. The company noted that the hydrophobic acrylic lens ...
9/4/2026
BreakingCataractGlaucomaIOLIndustryPharmaSurgical
SpyGlass Celebrates Grand Opening of New Irvine, California, Headquarters
SpyGlass Pharma celebrated the grand opening of its new Irvine, California, headquarters on Aug. 27, as the company continues to expand. SpyGlass was initially founded in Irvine in 2019 by Malik Y....
8/21/2026
BiosimilarsBreakingDiagnosticIOLPharmaRetinaRevenueSurgical
Quarterly Revenue Roundup for Carl Zeiss Meditec and Santen
German company Carl Zeiss Meditec reported Aug. 6 that its ophthalmic device revenue for the three months ended June 2026 (the third quarter of its fiscal 2025/2026 year) was €437.6 million ($499.7...
8/20/2026
CataractDealsIOLNewsletter
Alcon Drops Development of PowerVision Accommodating Lens
Alcon reported Aug. 10 in its Q2-2026 earnings report that it had discontinued work on the PowerVision FluidVision accommodating IOL, following analysis of the latest clinical study data. Alcon sai...
8/20/2026
CataractChinaClinical TrialCornealDealsDiagnosticDry EyeFundingGene TherapyGlaucomaIOLNewsletterPharmaRetinaSurgical
Tarsus Leads Latest Fundraising with $125 Million Private Placement
Tarsus Pharmaceuticals led recent ophthalmic fundraising efforts with a $125 million private placement for clinical development and commercial activities. Financing announced in the past four weeks...
8/20/2026
AllergyCataractChinaDealsDiagnosticDry EyeEuropeFundusGene TherapyGlaucomaIOLIndustryLow VisionMyopiaNewsletterPharmaPresbyopiaRefractiveRegulationRetinaSurgical
August 2026 Ophthalmic News Briefs
Bausch + Lomb announced July 16 that it had launched the EyeGility Inserter preloaded IOL delivery system in the US. The inserter is available now with the enVista Aspire intermediate-optimized mon...
8/14/2026
BreakingCataractDry EyeGlaucomaIOLOcular CancerPharmaRetinaRevenueSurgical
Q2-2026 Ophthalmic Revenue Roundup for Alcon, Tarsus, Immunocore, Harrow, Sight Sciences, and ANI
Alcon reported Aug. 10 that its Q2-2026 net sales totaled $2.8 billion, an 8 percent increase over $2.6 billion in Q2-2025. Alcon also announced that it had discontinued work on the PowerVision Flu...
8/7/2026
BiosimilarsBreakingCataractIOLLaserPharmaRetinaRevenueSurgicalThyroid Eye Disease
Q2-2026 Ophthalmic Revenue Roundup for Regeneron, Amgen, Hoya, Astellas, Novartis, Lumibird, Ocular Therapeutix, and Xbrane
Regeneron, of Tarrytown, New York, reported July 30 that its Q2-2026 US revenue for Eylea HD and Eylea 2 mg was $1.0 billion, a 12 percent decrease from $1.15 billion in Q2-2025. Eylea HD accounted...
7/31/2026
BreakingCataractCornealDry EyeGene TherapyGlaucomaIOLMIGSPharmaRetinaRevenueSurgical
Q2-2026 Ophthalmic Revenue Roundup for Bausch + Lomb, Roche, and Glaukos
Bausch + Lomb reported July 29 that its Q2-2026 revenue was $1.4 billion, a 9 percent increase over $1.3 billion in Q2-2025, driven by a 64 percent increase in implantables, including a 175 percent...
7/31/2026
BreakingCataractIOLPremiumSurgical
Bausch + Lomb Launches EyeGility Preloaded IOL Inserter in the US
Bausch + Lomb announced July 16 that it had launched the EyeGility Inserter preloaded IOL (intraocular lens) delivery system in the US. The inserter is available now with the enVista Aspire interme...
7/21/2026
CataractIOLNewsletterPremiumRoboticsSurgical
Robotic Cataract Surgery Can Serve as Catalyst for Premium Growth
Robotic cataract surgery remains a hot topic in ophthalmology, fueled by recent first-in-human procedures and a growing pipeline of robotic platforms. A digitally guided, highly precise surgical sy...
7/21/2026
DealsIOLNewsletter
RxSight to Collaborate with Alcon on PC-IOLs Under New CEO
RxSight has made two significant moves following disappointing sales results in Q2-2026. The Aliso Viejo, California, company announced July 6 that it would collaborate with Alcon to develop adjust...
7/21/2026
DiagnosticIOLNewsletterRegulation
Select US FDA Approvals and Clearances in June 2026
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in June 2026, according to the agency’s database. Topcon received clearance for the Harmony Refer...
7/21/2026
AICataractChinaDealsDiagnosticDigitalFundusGlaucomaIOLIndustryNewsletterPharmaRefractiveRegulationRetinaSurgical
July 2026 Ophthalmic News Briefs
Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution for its Acuvue con...
7/17/2026
BreakingCataractIOLIndustrySurgical
RxSight Appoints Aziz Mottiwala as President, CEO
RxSight reported July 15 that it had appointedAziz Mottiwala as president and chief executive officer, effective July 20. Mottiwala succeeds Ron Kurtz, MD, who will continue to serve as chief medic...
7/17/2026
BreakingCataractIOLPremiumRevenueSurgical
J&J Vision Generates Q2-2026 Surgical Revenue of $426 Million
J&J Vision’s Q2-2026 global surgical revenue totaled $426 million, a 5.6 percent increase over $403 million in Q2-2025, parent Johnson & Johnson, of New Brunswick, New Jersey, reported July 15. Q2-...
7/10/2026
BreakingCataractDealsIOLPremiumPresbyopiaSurgical
Alcon and RxSight to Collaborate on Developing Adjustable PC-IOLs
Alcon and RxSight willjointly develop adjustable presbyopia-correcting intraocular lenses (PC-IOLs) under a new nonexclusive agreement, the companies announced July 6. The collaboration aims to com...
7/10/2026
BreakingCataractIOLPremiumStudySurgical
Global Team of Ophthalmologists Creates Questionnaire for Reporting Dysphotopsias
Twenty multinational ophthalmic specialists, including key opinion leaders, have developed a consensus-based classification system and questionnaire for reporting dysphotopsias after ophthalmic pro...
6/19/2026
BreakingCataractIOLSurgical
J&J Expands US Rollout of Tecnis PureSee IOL
Johnson & Johnson reported June 11 that it was expanding availability for the Tecnis PureSee IOL in the US. The lens gained US FDA approval in March 2026. The PureSee is a purely refractive extende...
6/18/2026
GlaucomaIOLNewsletterRefractiveRetina
Ophthalmologists Report 4.7 Percent Decrease in Q1-2026 Procedure Volume
US ophthalmologists reported that ophthalmic procedures decreased 4.7 percent in Q1-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...
6/18/2026
CataractGlaucomaIOLNewsletterRegulation
SpyGlass Gains Category III CPT Code for Its Drug-Eluting BIM-IOL System
SpyGlass Pharma, of Aliso Viejo, California, reported May 18 that the American Medical Association had approved a new add-on Category III CPT code that will allow surgeons to be reimbursed separate...
6/18/2026
DiagnosticIOLNewsletterRegulationRetina
Select US FDA Approvals and Clearances in May 2026
The US FDA’s ophthalmic device division granted clearance to two devices using the 510(k) pathway in May 2026, according to the agency’s database. Heidelberg received clearance for its updated Spec...
6/18/2026
CataractFLACSIOLNewsletterPremium
Weekly Poll of MDs, US Only, June 2026
6/18/2026
AIAllergyAmblyopiaCataractClinical TrialDealsDiagnosticIOLIndustryLaserMicroscopesMyopiaNewsletterOptometryPharmaRegulationRetinaSingle-UseSurgical
June 2026 Ophthalmic News Briefs
UK-based Rayner announced June 1 the launch of Ophteis Cohesive, a new OVD formulated with a high molecular weight to optimize space creation and ease of removal. Ophteis Cohesive is packaged at 1....
5/29/2026
BreakingCataractGlaucomaIOL
SpyGlass Gains Category III CPT Code for Its Drug-Eluting BIM-IOL System
SpyGlass Pharma, of Aliso Viejo, California, reported May 18 that the American Medical Association had approved a new add-on Category III CPT code that will allow surgeons to be reimbursed separate...
5/29/2026
BreakingCataractDiagnosticIOL
Carl Zeiss Meditec Names Bronwyn Brophy O’Connor as CEO
German company Carl Zeiss Meditec reported May 22 that it had appointed Bronwyn Brophy O’Connor as chief executive officer and a member of the management board. Zeiss said O’Connor brings 25 years ...
5/29/2026
BreakingCataractIOL
Patients Satisfied with Same-Day Bilateral Cataract Surgery, Study Finds
Danish researchers who interviewed same-day bilateral cataract surgery patients found that the patients appreciated the convenience and welcomed empathetic communication before, during, and after t...
5/22/2026
BreakingCataractIOLPharma
Annual and Quarterly Ophthalmic Revenue Roundup for Santen, Carl Zeiss Meditec, Harrow, RxSight, ANI, and Lensar
Japan-based Santen reported May 12 that its revenue for its fiscal year 2025, which ended March 31, 2026, was JPY 291.6 billion ($1.8 billion, calculated for March 31, 2026), a 2.8 percent decline ...
5/14/2026
ASCRSCataractIOLMeetingNewsletterRefractive
2026 ASCRS Meeting Adds Patriotic Pomp, Lighter Features to Program
A wave of IOL launches dominated the 2026 meeting of the American Society of Cataract and Refractive Surgery (ASCRS), highlighting intensifying competition across the premium IOL space. But confere...
5/14/2026
ASCRSCataractIOLMeetingNewsletter
IOL Makers Go All in to Launch Premium Lenses at ASCRS Meeting
Johnson & Johnson Vision, BVI Medical, and Alcon showcased the strengths of their latest IOLs throughout the 2026 ASCRS meeting, explaining how their technology benefits the growing premium space. ...
5/14/2026
ASCRSCataractIOLMeetingNewsletterSurgical
Surgeons Share Experience With Three of Rayner’s Technologies
Ophthalmologists took a deep dive into describing their experience with two of Rayner’s newest IOLs—the RayOne Galaxy and RayOne EMV Toric—along with the company’s Sophi phaco system at a Rayner-sp...
5/14/2026
CataractClinical TrialCornealGene TherapyIOLNewsletterRetinaSurgicalThyroid Eye Disease
Clinical Trial Updates for Ophthalmic Candidates, May 2026
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
5/8/2026
BiosimilarsBreakingCataractIOLRetinaRevenueSurgicalThyroid Eye Disease
Quarterly Ophthalmic Revenue Roundup for Alcon, Amgen, Hoya, Ocular Therapeutix, and Xbrane
Alcon reported May 6 that its Q1-2026 net sales were $2.69 billion, a 10 percent increase (+6 percent cc) over $2.45 billion in Q1-2025. Surgical net sales totaled $1.46 billion, consisting of $438...
5/1/2026
BreakingCataractCornealGlaucomaIOLLaserPharmaRetinaRevenueSurgical
Q1-2026 Ophthalmic Revenue Roundup for Bausch + Lomb, Regeneron, Glaukos, Astellas, Novartis, and Lumibird
Bausch + Lomb reported April 29 that its Q1-2026 revenue was $1.24 billion, a 9 percent increase (+6 percent cc) over $1.14 billion in Q1-2025. Surgical segment revenue was $228 million, a 7 percen...
5/1/2026
BreakingCataractClinical TrialIOLPharma
US FDA Gives Green Light to Trial of LayerBio’s OcuRing-K for Post-op Inflammation and Pain
Israel’s PRF Technologies and its majority-owned subsidiary LayerBio reported on April 28 that the US FDA had signed off on their investigational new drug (IND) application, allowing LayerBio to pr...
4/21/2026
CataractIOLNewsletterOptometryPremium
New OD Survey Looks at Factors Shaping Premium IOL Education Before Referral
Optometrists play an increasingly important role in educating patients about cataract surgery prior to referral, as those patients’ expectations continue to rise. Key findings from Market Scope’s i...
4/21/2026
CataractDiagnosticIOLNewsletterRetina
Select US FDA Approvals and Clearances in March 2026
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in March 2026, according to the agency’s database. Oculus received clearance for its Pentacam Cor...
4/21/2026
CataractIOLNewsletter
Bausch + Lomb Launches Preloaded enVista Envy Trifocal IOL in Europe
Bausch + Lomb announced April 7 the commercial availability in Europe of the enVista Envy trifocal intraocular lens (IOL), preloaded in the EyeGility lens delivery system. Luc Bonnefoy, president o...
4/21/2026
ASCRSCornealDiagnosticDry EyeGlaucomaIOLMeetingNewsletterOCTSurgical
Meeting-Related Launches Include Range of Ophthalmic Products
Several ophthalmic companies launched products at the 2026 annual meeting of the American Society of Cataract and Refractive Surgery, held April 10-13 in Washington, DC. Market Scope will be coveri...
4/21/2026
ChinaClinical TrialEmergingGlaucomaIOLNewsletterProsthesisRetina
Emerging Companies Pursuing Ophthalmic Indications, April 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
4/21/2026
BiosimilarsCataractCell TherapyChinaClinical TrialCornealDiagnosticDigitalDry EyeIOLIndiaIndustryMicroscopesNewsletterPharmaRegulationRetina
April 2026 Ophthalmic News Briefs
Swiss ophthalmic diagnostics company Haag-Streit announced March 31 the global launch of its Metis 3D Digital Heads-Up Module (Metis HU). The system was launched in the US in October 2025. Metis HU...
4/17/2026
BreakingCataractIOLRevenueSurgical
J&J Reports Q1-2026 Surgical Vision Revenue of $396 Million
Johnson & Johnson reported April 14 that its Q1-2026 global surgical vision revenue totaled $396 million, a 9.7 percent increase over $361 million in Q1-2025. Q1-2026 surgical vision revenue in the...
4/10/2026
BreakingCataractIOLSurgical
Alcon Launches Clareon TruPlus Enhanced Monofocal IOL at ASCRS 2026
Alcon announced the US launch of the Clareon TruPlus enhanced monofocal intraocular lens (IOL), along with a toric version, at the 2026 meeting of the American Society of Cataract and Refractive Su...
4/10/2026
BreakingCataractEuropeIOLSurgical
Bausch + Lomb Launches Preloaded enVista Envy Trifocal IOL in Europe
Bausch + Lomb announced April 7 the commercial availability in Europe of the enVista Envy trifocal intraocular lens (IOL), preloaded in the EyeGility lens delivery system. Luc Bonnefoy, president o...
4/10/2026
BreakingCataractIOLIndustrySurgical
Lenstec Appoints Blake Michaels as Chief Executive Officer
Lenstec announced on LinkedIn April 6 that it had appointed Blake Michaels as its new chief executive officer. Lenstec, of St. Petersburg, Florida, markets ClearView and Softec intraocular lenses (...
4/3/2026
BreakingCataractIOLSurgical
VirtuaLens IOL Simulator Now Includes Monovision Feature
VirtuaLens, of Austin, Texas, reported March 23 that its intraocular lens (IOL) simulator now offers a monovision feature. The wireless VR headset is designed to help patients understand their opti...
4/3/2026
BreakingCataractClinical TrialIOLRegulationSurgical
US FDA Gives Green Light to Trial of Long Bridge’s Prosthetic Capsular Bag
Long Bridge Medical announced March 26 that the US FDA had signed off on its investigational device exemption (IDE) submission, allowing the company to proceed with a pivotal trial of LensOne, its ...
3/24/2026
GlaucomaIOLNewsletterRefractiveRetina
Ophthalmologists Report 2.1 Percent Decrease in Q4-2025 Procedure Volume
------ Refractive: -17.3 IOL: +5.0 Glaucoma: +4.2 Retina: -5.7 ----- US ophthalmologists reported that ophthalmic procedures decreased 2.1 percent in Q4-2025 compared with the same quarter in 2024,...
3/24/2026
CataractIOLNewsletterSurgical
Premium IOLs Move Mainstream as Revenue Growth Accelerates Globally
The unprecedented premium IOL growth seen over the past five years is expected to continue over the next five years, with premium IOL revenue projected to account for $5.4 billion and 57 percent of...
3/24/2026
CataractIOLNewsletterRegulationSurgical
J&J Vision Gains US FDA Approval for Tecnis PureSee EDOF IOL
Johnson & Johnson Vision announced March 12 that it had gained US FDA approval for the Tecnis PureSee, an extended depth of focus (EDOF) intraocular lens (IOL) for use in cataract surgery. The Jack...
3/24/2026
CataractIOLIndustryNewsletterSingle-UseSurgical
Rayner Expands US Headquarters in Memphis Amid Milestone Successes
Rayner reported March 9 that it had opened a new 10 thousand-square-foot facility in Memphis, Tennessee, which will serve as its expanded US headquarters. The UK-based company said the move signifi...
3/24/2026
BiosimilarsCataractClinical TrialCornealDealsDiagnosticEuropeFundingGlaucomaIOLIndustryNewsletterPresbyopiaRefractiveRegulationRetinaStudySurgical
March 2026 Ophthalmic News Briefs
STAAR Surgical announced Feb. 17 that the US FDA had approved an expanded age indication for Evo and Evo+ implantable Collamer lenses (ICLs), extending their use from patients 21 to 45 years old to...
3/13/2026
BreakingCataractIOLRegulationSurgical
J&J Vision Gains US FDA Approval for Tecnis PureSee EDOF IOL
Johnson & Johnson Vision announced March 12 that it had gained US FDA approval for the Tecnis PureSee, an extended depth of focus (EDOF) intraocular lens (IOL) for use in cataract surgery. The Jack...
3/13/2026
BreakingCataractIOLIndustrySingle-UseSurgical
Rayner Expands US Headquarters in Memphis Amid Milestone Successes
Rayner reported March 9 that it had opened a new 10 thousand-square-foot facility in Memphis, Tennessee, which will serve as its expanded US headquarters. The UK-based company said the move signifi...
3/13/2026
BreakingCataractDigitalIOLMicroscopesSurgical
Cassini Gains MDR Approval for Surgical Guidance System in the EU
Cassini Technologies, of the Netherlands, announced March 5 that its intraoperative guidance system for ophthalmic surgery had gained EU marketing authorization under the Medical Device Regulation ...
3/6/2026
BiosimilarsBreakingCataractEuropeIOLPharmaRetinaRevenueSurgicalUveitis
Ophthalmic Quarterly and 2025 Revenue for Carl Zeiss Meditec, Harrow, RxSight, ANI, and Xbrane
Million Carl Zeiss Meditec reported Feb. 12 that ophthalmology revenue for the last three months of 2025, the first quarter of its fiscal year 2025/2026, totaled €356.9 million ($419.2 million, con...
2/23/2026
CataractClinical TrialCornealGene TherapyGlaucomaIOLNewsletterPharmaRetina
Clinical Trial Updates for Ophthalmic Candidates, February 2026
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
2/23/2026
CataractClinical TrialCornealDealsDiagnosticDry EyeIOLNewsletterRefractiveRegulationRetinaSurgicalUveitis
February 2026 Ophthalmic News Briefs
Belgian investment company Groupe Bruxelles Lambert (GBL) reported Feb. 9 that it would invest 500 million euros (US $594 million, calculated on Feb. 11, 2026) in UK-based ophthalmic company Rayner...
2/20/2026
BreakingCataractCornealDry EyeGlaucomaIOLRevenueSurgical
2025 Ophthalmic Revenue Roundup for Bausch + Lomb and Glaukos
Bausch + Lomb reported Feb. 18 that its 2025 revenue totaled $5.1 billion, a 6 percent increase over $4.8 billion in 2024. The company’s Q4-2025 revenue was $1.4 billion, a 10 percent increase over...
2/13/2026
BreakingCataractDealsIOLPrivate EquitySurgical
Belgian Company Invests 500 Million Euros for 45 Percent Stake in Rayner
Belgian investment company Groupe Bruxelles Lambert (GBL) reported Feb. 9 that it would invest 500 million euros (US $594 million, calculated on Feb. 11, 2026) in UK-based ophthalmic company Rayner...
2/12/2026
BiosimilarsBreakingDiagnosticIOLLaserRetinaRevenueThyroid Eye Disease
2025 and Quarterly Ophthalmic Revenue Roundup for Amgen, Santen, Hoya, Lumibird, and Ocular Therapeutix
Amgen, of Thousand Oaks, California, reported Feb. 3 that its 2025 revenue for Tepezza was $1.90 billion, a 3 percent increase over $1.85 billion in 2024, primarily driven by higher net selling pri...
2/12/2026
BreakingChinaDealsIOLRefractiveSurgical
Arctic Vision to Acquire MDCO Technology’s Ophthalmic Device Business
China’s Arctic Vision announced Feb. 2 that it would acquire the ophthalmic device business of MDCO Technology. Arctic Vision said MDCO markets a premium intraocular lens (IOL), a phakic lens, and ...
1/23/2026
BreakingCataractIOLRevenueSurgical
J&J Vision Reports 2025 Surgical Vision Revenue of $1.6 Billion
Johnson & Johnson reported Jan. 21 that its full year 2025 global surgical vision revenue was $1.6 billion, a 10.2 percent increase over $1.4 billion in 2024. Revenue was up 6.1 percent in the US a...
1/23/2026
BreakingCataractGlaucomaIOLIndustryRetinaSurgical
BVI Medical Appoints Jim Hollingshead, PhD, as President and CEO
BVI Medical announced Jan. 19 that it had appointed Jim Hollingshead, PhD, as president and chief executive officer. Hollingshead succeeds Shervin Korangy, who will continue to serve as an advisor ...
1/21/2026
CataractCornealDealsIOLMyopiaNewsletterRefractiveRegulationRetinaSurgical
2025 in Review: Corporate and Surgeon Rankings of Top 10 Stories
Market Scope asked industry participants and surgeons to select the top story for 2025. Below are their choices. STAAR Calls Off Alcon Acquisition Deal after Failed Vote by Shareholders Turmoil Rei...
1/21/2026
CataractFLACSGlaucomaIOLNewsletterRevenueSurgical
2025 in Review: Bausch + Lomb Bounces Back from IOL Recall, Plans Busy Launch Schedule
Bausch + Lomb turned around a global recall of its enVista intraocular lenses (IOLs) in under a month in the spring of 2025, after facing a worst-case scenario for any medical device manufacturer: ...
1/21/2026
CataractIOLNewsletterPresbyopiaSurgical
2025 in Review: Next-Generation PC-IOL Designs Drive Global Market Expansion in 2025
Global demand in 2025 for presbyopia-correcting intraocular lenses (PC-IOLs) increased meaningfully, driven by improved optical performance, broader participation by leading IOL manufacturers, decl...
12/16/2025
GlaucomaIOLNewsletterRefractiveRetina
Ophthalmologists Report 2.6 Percent Decrease in Q3-2025 Procedure Volume
US ophthalmologists reported that ophthalmic procedures decreased 2.6 percent in Q3-2025 compared with the same quarter in 2024, according to Market Scope’s latest survey. Year-over-year performanc...
12/16/2025
CataractDiagnosticIOLNewsletterRegulation
Select US FDA Approvals and Clearances in November 2025
The US FDA’s ophthalmic device division granted clearance to two devices using the 510(k) pathway in November 2025, according to the agency’s database. Topcon received clearance for its TRK-3 Omnia...
12/16/2025
GlaucomaIOLIndustryNewsletterPharmaRetinaSurgical
Bausch + Lomb Outlines Growth Plans, Driven by Deep Pipeline
Bausch + Lomb used its investor day on Nov. 13 to lay out how it plans to produce growth of 6 to 8 percent in its surgical segment and 5 to 7 percent in its pharmaceutical, consumer, and contact le...
12/5/2025
BreakingCataractDealsDry EyeFLACSGlaucomaIOLPharmaSurgical
Bausch + Lomb Outlines Growth Plans, Driven by Deep Pipeline
Bausch + Lomb used its investor day on Nov. 13 to lay out how it plans to produce growth of 6 to 8 percent in its surgical segment and 5 to 7 percent in its pharmaceutical, consumer, and contact le...
11/19/2025
IOLLaserNewsletterRegulation
Select US FDA Approvals and Clearances in October 2025
The US FDA’s ophthalmic device division granted clearance to one device using the 510(k) pathway in October 2025, according to the agency’s database. OD-OS gained clearance for its Navilas 577sl la...
11/19/2025
AcquisitionsDealsIOLNewsletterRefractive
STAAR Solicits New Bids Under Amended Deal with Alcon, Moves Shareholder Vote to Dec. 19
STAAR Surgical reported Nov. 7 that it had amended its merger agreement with Alcon to allow STAAR to solicit new buyers for 30 days under a new “go-shop” period ending Dec. 6. STAAR also delayed to...
11/19/2025
Clinical TrialCornealGene TherapyGlaucomaIOLMIGSNewsletterRetinaUveitis
Clinical Trial Updates for Ophthalmic Candidates, November 2025
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
11/14/2025
BreakingDry EyeFLACSGlaucomaIOLLaserMIGSOcular CancerPharmaRefractiveRetinaRevenueSurgical
Q3-2025 Ophthalmic Revenue Roundup for Alcon, Santen, Immunocore, STAAR, Harrow, and Five Others
Alcon reported Nov. 11 that its Q3-2025 net sales totaled $2.6 billion, a 6 percent increase over $2.4 billion in Q3-2024. Surgical net sales for implantables, consumables, and equipment/other were...
11/7/2025
BiosimilarsBreakingDry EyeGlaucomaIOLLaserPresbyopiaRetinaRevenueSurgicalThyroid Eye Disease
Q3-2025 Ophthalmic Revenue Roundup for Amgen, AbbVie, Hoya, Glaukos, Apellis, Astellas, and Four Others
Amgen, of Thousand Oaks, California, reported Nov. 4 that its Q3-2025 revenue from Tepezza was $560 million, a 15 percent increase over $488 million in Q3-2024. The total consisted of $518 million ...
10/31/2025
BreakingCataractDry EyeIOLPharmaRetinaRevenueSurgical
Q3-2025 Ophthalmic Revenue Roundup for Bausch + Lomb, Roche, Regeneron, Novartis
Bausch + Lomb reported Oct. 29 that its Q3-2025 revenue totaled $1.3 billion, a 7 percent increase over $1.2 billion in Q3-2024. Ophthalmic pharmaceuticals segment revenue was $330 million, an 8 pe...
10/24/2025
BreakingCataractIOLRevenueSurgical
J&J Vision Surgical Posts Q3-2025 Revenue of $383 Million
J&J Vision’s Q3-2025 global surgical vision revenue totaled $383 million, a 14.9 percent increase over $333 million in Q3-2024, parent Johnson & Johnson, of New Brunswick, New Jersey, reported Oct....
10/23/2025
CataractFLACSIOLNewsletterPremiumSurgical
Premium Cataract Surgery Growth Increasingly Led by International Markets
International markets have disproportionately driven growth in the global premium cataract surgery (PCS) market since 2018. The market is expected to approach $3.2 billion in 2025, fueled by improv...
10/23/2025
CataractIOLNewsletterRegulationSurgical
Rayner Gains US FDA Approval of RayOne EMV Toric IOL
UK-based Rayner announced Oct. 13 that the US FDA had approved its RayOne EMV Toric intraocular lens (IOL), and the lens is now available. Rayner CEO Tim Clover said: “The long-awaited FDA approval...
10/23/2025
CataractIOLNewsletterRegulationSurgical
BVI’s FineVision HP Trifocal IOL Gains US FDA Approval; Rollout Set for 2026
BVI Medical announced Oct. 14 that the US FDA had approved its FineVision HP trifocal intraocular lens (IOL). The company said the lens, the world’s first trifocal IOL, was backed by 15 years of cl...
10/23/2025
CataractCornealDiagnosticFundusIOLMyopiaNewsletterRegulationSurgical
Select US FDA Approvals and Clearances in September 2025
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in September 2025, according to the agency’s database. Medicel gained clearance for its Accuject ...
10/23/2025
Clinical TrialGene TherapyGlaucomaIOLLow VisionNewsletterPharmaRetina
Clinical Trial Updates for Ophthalmic Candidates, October 2025
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
10/17/2025
BreakingCataractIOLRegulationSurgical
BVI Medical’s FineVision HP Trifocal IOL Gains US FDA Approval
BVI Medical announced Oct. 14 that the US FDA had approved its FineVision HP trifocal intraocular lens (IOL). The company said the lens, the world’s first trifocal IOL, was backed by 15 years of cl...
10/17/2025
BreakingCataractEuropeIOLSurgical
Biotech Healthcare Launches Optiflex Xtense Comfort Plus EDOF IOL in Europe
Biotech Healthcare announced Sept. 23 that it had launched the Optiflex Xtense Comfort Plus extended-depth-of-focus (EDOF) intraocular lens at the ESCRS 2025 congress in Copenhagen, Denmark. Biotec...
10/13/2025
BreakingCataractIOLSurgical
Rayner Gains US FDA Approval of RayOne EMV Toric IOL
UK-based Rayner announced Oct. 13 that the US FDA had approved its RayOne EMV Toric intraocular lens (IOL), and the lens is now available. Rayner CEO Tim Clover said: “The long-awaited FDA approval...
9/22/2025
GlaucomaIOLNewsletterRefractiveRetina
Ophthalmic Company Revenue Down 1.9 Percent in Q2-2025 as Multiple Firms Report Declines
Ophthalmic manufacturer revenue in Q2-2025 totaled $11.7 billion. Revenue decreased 1.9 percent from the same quarter in 2024 and increased 6.3 percent from Q1-2025. The total includes Market Scope...
9/22/2025
CataractGlaucomaIOLNewsletterRefractiveRetinaSurgical
Ophthalmologists Report 2.2 Percent Increase in Q2-2025 Procedure Volume
US ophthalmologists reported that ophthalmic procedures increased 2.2 percent in Q2-2025 compared with the same quarter in 2024, according to Market Scope’s latest survey. Year-over-year performanc...
9/5/2025
BreakingCataractClinical TrialIOLSurgical
Ocumetics Implants First Patients in Trial of its Accommodating IOL
Ocumetics Technology, of Calgary, Canada, announced Aug. 18 that the first patients had been implanted in a clinical study of its accommodating intraocular lens (IOL). The company said the procedur...
8/15/2025
BreakingCataractIOLSurgical
VSY Biotechnology Launches Enova Hydrophobic IOLs with Rotaryjet Inserter
Germany’s VSY Biotechnology announced Aug. 8 that its Enova hydrophobic intraocular lens (IOL) line was now available with the company’s Rotaryjet preloaded delivery system. VSY said the Rotaryjet ...
8/8/2025
BiosimilarsBreakingDry EyeGlaucomaIOLPresbyopiaRetinaRevenueSurgicalThyroid Eye Disease
Q2-2025 Ophthalmic Revenue Roundup for Regeneron, Amgen, AbbVie, Hoya, and Ocular Therapeutix
Regeneron, of Tarrytown, New York, reported Aug. 1 that its Q2-2025 US revenue for Eylea HD and Eylea 2 mg was $1.15 billion, a 25 percent decrease from $1.53 billion in Q2-2024. Eylea HD accounted...
8/1/2025
BreakingCataractCornealGlaucomaIOLRetinaRevenueSurgical
Q2-2025 Ophthalmic Revenue Roundup for Roche, Bausch + Lomb, Apellis, Glaukos, and Astellas
Swiss company Roche reported July 24 that Vabysmo sales for Q2-2025 were CHF 1.05 billion ($1.3 billion, converted June 30, 2025), a 19 percent increase over CHF 947 million in Q2-2024. Roche said ...
7/22/2025
CataractIOLNewsletterPremiumSurgical
J&J Vision Launches Tecnis Odyssey PC-IOL in Europe, Middle East, and Canada
Johnson & Johnson Vision announced June 17 that it had rolled out the Tecnis Odyssey presbyopia-correcting intraocular lens (PC-IOL) in Europe, the Middle East, and Canada. The Odyssey had previous...
7/18/2025
BreakingCataractIOLRevenueSurgical
J&J Vision Generates Q2-2025 Surgical Revenue of $403 Million
J&J Vision’s Q2-2025 global surgical revenue totaled $403 million, a 9.9 percent increase (+8.9 percent cc) over $367 million in Q2-2024, parent Johnson & Johnson, of New Brunswick, New Jersey, rep...
7/18/2025
BreakingCataractClinical TrialIOLSurgical
Ocumetics Set to Begin First-in-Human Study of its Accommodating IOL
Ocumetics Technology, of Calgary, Canada, announced June 24 that it was set to begin a first-in-human clinical study of its accommodating intraocular lens (IOL). The company said all the lenses for...
7/11/2025
BreakingCataractIOLRevenueSurgical
RxSight Lowers 2025 Guidance Due to Q2-2025 Preliminary Results
RxSight reported July 8 that it was lowering its 2025 revenue guidance to $120 million to $130 million, down from the range of $185.0 million to $197.0 million provided on Feb. 25, 2025. The Aliso ...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.